Literature DB >> 10101428

Syphilis in Murewa District, Zimbabwe: an old problem that rages on.

R A Kambarami1, B Manyame, J Macq.   

Abstract

OBJECTIVE: To determine the prevalence of syphilis among pregnant women and women giving birth in health centres in a rural district and to identify problems associate with syphilis control in the same district.
DESIGN: Cross sectional descriptive study.
SETTING: Murewa District health facilities.
SUBJECTS: Women attending health facilities in this district for antenatal care or delivery between February and May 1993. MAIN OUTCOME MEASURES: Syphilis sero-prevalence rate. Factors associated with poor syphilis control.
RESULTS: Even though it is recommended that all women attending clinics for antenatal care (ANC) should be screened for syphilis at first visit only 308 (20%) out of 1,556 first visit attenders were screened during the study period. Three hundred and sixty six (33%) out of 1,096 women giving birth in health institutions were screened. The RPR/TPHA sero positivity rate for antenatal women was 9.2% while that for women delivering was 9.8%. A positive RPR was not significantly associated with the women's age, parity, infant's birth weight, sex or pregnancy outcome. Factors associated with poor syphilis control in this district included: lack of motivation and appreciation of the seriousness of syphilis in pregnancy; lack of transport to send specimens and receive results from Murewa District Hospital; poor record keeping; loss to follow up of women being tested or after starting treatment; lack of contact tracing and treatment of contacts and difficulties in implementing the 10 day neonatal regime and follow up of these infants.
CONCLUSION: Syphilis remains poorly controlled in Murewa district and may be contributing significantly to high perinatal mortality rates. There is need to strengthen the syphilis control programme through motivation and training of health workers, decentralisation of testing and treatment of the condition and improved contact tracing. A repeat RPR test at delivery may not be cost effective.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Cross Sectional Analysis; Demographic Factors; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Infections; Measurement; Population; Population Characteristics; Pregnant Women; Prevalence; Reproductive Tract Infections; Research Methodology; Research Report; Rural Population--women; Sexually Transmitted Diseases; Syphilis--women; Women; Zimbabwe

Mesh:

Year:  1998        PMID: 10101428

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  5 in total

1.  An intervention study to reduce adverse pregnancy outcomes as a result of syphilis in Mozambique.

Authors:  N Bique Osman; K Challis; E Folgosa; M Cotiro; S Bergström
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

2.  Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 Trial in Malawi, Tanzania, and Zambia.

Authors:  Dara Potter; Robert L Goldenberg; Jennifer S Read; Jing Wang; Irving F Hoffman; Elmar Saathoff; George Kafulafula; Said Aboud; Francis E A Martinson; Maysoon Dahab; Sten H Vermund
Journal:  Sex Transm Dis       Date:  2006-10       Impact factor: 2.830

3.  Prevalence and risk factors of syphilis infection among drug addicts.

Authors:  Norbert Scherbaum; Bernhard T Baune; Rafael Mikolajczyk; Thomas Kuhlmann; Gerhard Reymann; Martin Reker
Journal:  BMC Infect Dis       Date:  2005-05-17       Impact factor: 3.090

4.  Incidence of stillbirth and perinatal mortality and their associated factors among women delivering at Harare Maternity Hospital, Zimbabwe: a cross-sectional retrospective analysis.

Authors:  Shingairai A Feresu; Siobán D Harlow; Kathy Welch; Brenda W Gillespie
Journal:  BMC Pregnancy Childbirth       Date:  2005-05-05       Impact factor: 3.007

5.  Risk Factors for Low Birthweight in Zimbabwean Women: A Secondary Data Analysis.

Authors:  Shingairai A Feresu; Siobán D Harlow; Godfrey B Woelk
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.